Switch to:
More From Other Websites
Peter G. Traber, M.D., CEO and CMO of Galectin Therapeutics, to Speak on the Medical Applications of... Jul 13 2016
Peter G. Traber, M.D., CEO and CMO of Galectin Therapeutics, to Speak on the Medical Applications of... Jul 13 2016
Galectin Therapeutics Receives Notice of Australian Patent to be Granted for the Use of GR-MD-02 in... Jul 12 2016
Galectin Therapeutics Receives Notice of Australian Patent to be Granted for the Use of GR-MD-02 in... Jul 12 2016
Galectin Therapeutics Receives Notice of Australian Patent to be Granted for the Use of GR-MD-02 in... Jul 12 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 20 2016
Galectin Therapeutics Announces Positive Preclinical Results on the Role of Galectin-3 in Mediating... Jun 02 2016
Galectin Therapeutics Announces Positive Preclinical Results on the Role of Galectin-3 in Mediating... Jun 02 2016
GALECTIN THERAPEUTICS INC Financials May 19 2016
Galectin Therapeutics Announces Positive Interim Results from Phase 2a Trial with GR-MD-02 in... May 16 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 16 2016
Galectin Therapeutics Announces Positive Interim Results from Phase 2a Trial with GR-MD-02 in... May 16 2016
Galectin Therapeutics Announces Complete Enrollment in its Phase 2 Trial with GR-MD-02 in NASH... May 11 2016
Galectin Therapeutics Announces Complete Enrollment in its Phase 2 Trial with GR-MD-02 in NASH... May 11 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 11 2016
Galectin Therapeutics Reports First Quarter 2016 Financial Results and Provides Business Update May 10 2016
Galectin Therapeutics Reports First Quarter 2016 Financial Results and Provides Business Update May 10 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 10 2016
GALECTIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report May 10 2016
Preclinical Research on the Role of Galectin-3 in Pulmonary Arterial Hypertension to be Presented at... May 05 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK